Top Trending Healthcare and Healthcare IT News: June 2020

Tuesday 30 June 2020

News : Non-alcoholic Steatohepatitis (NASH) Biomarkers Market size, Research Report, Analysis and Growth Factor

Market Overview

NAFLD's diagnosis is of particular significance due to the chances of its moving to more severe stages. In addition, in early-stage diagnosis instances, the use of specific strategies such as growing physical exercise and dietary modification may avoid unpleasantness of the disease. Except in more severe stages of the disease, like non-alcoholic steatohepatitis (NASH), it's still necessary to detect it as soon as possible because of the risk for cirrhosis progression.

Biomarkers are important for testing and treatment approaches for fatty liver disease cases and for faster diagnosis of potentially life threatening NASH and NAFLD. This will allow for the diagnosis and treatment of disease using a clear biomarker blood test, thereby preventing a biopsy of the liver. Managing the inherent comorbidities that produce NASH syndrome is possible, and the natural history of this daunting disease should increase. Furthermore, biomarker approaches will interface work in biomedicine.

The global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers Market is projected to witness a 20.92 percent CAGR and is expected to hit the US$1.960.4 million mark by 2024. The key factors that pave the way for the growth of the worldwide market for non-alcoholic steatohepatitis biomarkers are the expanding presence of NASH, growing need for non-invasive diagnostic testing and awareness-raising campaigns. On the opposite, the existence of stringent rules for the certification of biomarkers by the United States FDA is expected to slow the growth of the market during the forecast period.

Market Segmentation

The global market for non-alcoholic steatohepatitis biomarkers has been segmented on the basis of end users and type. Based on type, the market is segmented into Hepatic Fibrosis Biomarkers, Serum Biomarkers, and others. And by end user, the market segment covers CROs, pharmaceutical companies, and others. The study on the global market for non-alcoholic steatohepatitis biomarkers focuses on market value and size at corporate, local, and global levels. From a broader perspective, the study report portrays the total market size of non-alcoholic steatohepatitis biomarkers by examining existing market patterns, historical evidence and expectations for future development. Market revenue from various national markets has been applied to quantify the global market's total revenue. The study offers an outline of the solutions in the industry, and also demonstrates the pace of growth in the global market.

Regional Overview

Geographically, the global demand for non-alcoholic steatohepatitis biomarkers has been subdivided into MEA, Asia-Pacific, North America, Europe, and is sub-segmented into country level markets such as India, the United States, China, Japan, Australia, etc. The report provides comprehensive information from regional segments while covering local and global market size, regional market rivals, performance data, and statistics on exports and import. The study also discusses regional market patterns, trends, production and utilization rate of goods, revenue from the market sector, and the rate of growth. The report also covers the demand data from several industries and a wide range of opportunities present in the region that are expected to drive growth.

Industry News

Research has found a biomarker linked to the growth of non-alcoholic fatty liver disorder in human beings that could help doctors uncover early stages of the illness. The scientists also found that this biomarker, a protein classified as the 'neuronal regeneration-related protein', plays a critical role in controlling a mechanism that is now being investigated as a therapeutic choice for the condition in clinical trials.

Read More @ https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

News: Sarcoma Drugs Market Size, Research Report, Analysis, Trends and Forecast

Market Highlights

Spindle cell sarcoma is a very rare malignant tumor which can develop in bone or soft tissue. This tumor can arise in any part of the body but can be mostly seen in limbs. It is the type of connective tissue tumor and generally begins in the layer of connective tissues. Chemotherapy is the most important treatment for this disease. Various chemotherapy drugs are also used to cure this tumor. Spindle cell sarcoma is diagnosed by the presence of a tumor on the surface of the tissue and will be confirmed by carrying out various diagnostic tests such as X-rays, MRI scan, and other imaging devices.

Due to increase in aging population, and rising use of various treatment options to cure spindle cell sarcoma tumor and increasing investment in research and development by government and non-government organization are some of the factors that help boost the market in the forecast period.

The global spindle cell sarcoma treatment market is dominated by many market players. The key players in the market are engaged in new launches of chemotherapy drugs and strategic collaborations to hold its market position.

Access Report @ https://www.marketresearchfuture.com/reports/spindle-cell-sarcoma-treatment-market-6467

Regional Analysis

The market in the Americas is expected to dominate the global spindle cell sarcoma treatment market during the forecast period owing to the rising demand for chemotherapy drugs for the prevention of disease and for research and development. Additionally, the growing occurrences of spindle cell sarcoma are associated with the aging population is anticipated to boost the growth of the market in this region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the growing incidence of spindle cell sarcoma tumor problems. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income, increasing incidence of spindle cell sarcoma, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global spindle cell sarcoma treatment market. The market growth in this region can be attributed to increasing healthcare expenditure and developing healthcare infrastructure.

Segmentation
The global spindle cell sarcoma treatment market has been segmented on the basis of type of treatment and end-user.
On the basis of types of treatment, the market is segmented into surgical removal, cryotherapy, radiotherapy, hormone therapy, and chemotherapy. Surgical therapy is further segmented into conservative removal type and wide surgical removal type.
On the basis of end-user, the market is segmented into hospital, clinics, and others.
Key Players
Some of the key players in the global spindle cell sarcoma treatment market are PharmaEngine, Inc, Morphotek Inc, Threshold Pharmaceutical, Merck KGaA, NantCell Inc, NanoCarrier Co., Ltd, Athenex, Inc.
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

NEW Research : Cardiovascular Applications Market Size, Share, Analysis and Forecast

Cardiovascular applications include devices and equipment used in diagnosing, monitoring, and treatment of cardiovascular diseases. The increasing number of patients diagnosed with cardiovascular diseases is a definite growth enabler of these devices. The global cardiovascular application market report by Market Research Future (MRFR) highlights several trends and opportunities for end-users for the period of 2018 to 2023 (forecast period).

Market Scope

The global cardiovascular application market size can touch a value of USD 36,730.5 million by 2023. It can display a CAGR of 7.24% over the forecast period. Rising prevalence of cardiovascular diseases, the large vulnerable geriatric populace, and reimbursement policies are major drivers of the market. According to the World Health Organization (WHO), close to 17.7 million patients have died from cardiovascular diseases (CVDs). This can culminate in a spike in the demand for cardiovascular devices. Rise in cases of obesity can also act as a precursor to CVDs and spur market demand.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5255

Government efforts to reduce hospital acquired infections (HAIs) is expected to fuel market demand exponentially. It can result in the demand for diagnostic and monitoring devices. Adoption of remote patient monitoring and home healthcare are likely to spike the demand in home care centers and home settings. Rapid urbanization has led to the migration of various patients to cities, whose sedentary lifestyle has contributed to CVDs. Diagnostic devices and monitoring devices can make up for maximum sales of the cardiovascular application market owing to the need for devices for rapid diagnosis of diseases at an early stage.

However, strict regulations pertaining to their approval can impede market growth.

Segmentation

The global cardiovascular application market has been segmented into device, end user, and region. By device, the market has been segmented into cardiac monitors, cardiac pacemakers, and cardiac defibrillators. Cardiac monitors accounted for a market value of USD 6131.7 million in 2018.

Based on end user, the market has been divided into hospitals, cardiac care centers, ambulatory centers & home care, and academic centers.

Regional Analysis

The global cardiovascular application market covers the regions of the Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas accounted for a major market share owing to high healthcare spending, large number of cases of CVDs, and well-developed technology. The strong economic growth of the U.S. and Canada as well as the breakthroughs in medical devices can fuel the regional cardiovascular devices market. Adoption of home healthcare devices and rise of telemedicine are drivers of the market.

Europe accounted for the second-largest market share owing to a well-developed economy, healthcare budget, and increasing number of cases of obesity and diabetes. According to the World Health Organization (WHO), CVDs accounted for 46 times the mortality rates of citizens in comparison to tuberculosis, malaria, and AIDS. Digital platform which encourage home monitoring of patients with CVDs can bode well for the market.

APAC can exhibit the fastest growth rate during the forecast period owing to a large patient pool, improving technology, and need for advanced diagnostic devices. The geriatric population as well as allocation of funds in the corpus of healthcare budget of countries is factors which can influence the market. Rise in medical tourism as well as affordable surgeries and procedures conducted at affordable rates can drive the demand for these devices. Initiatives to modernize healthcare infrastructure and demand for advanced healthcare facilities are other drivers of the market.

Competitive Outlook

Koninklijke Philips NV, GENERAL ELECTRIC, Boston Scientific Corporation, Abbott, Stryker, Terumo Corporation, and Medtronic are major players of the global cardiovascular application market. Acquisitions, novel product launches, and innovational breakthroughs are strategies being implemented by players to gain the edge in the market.

Read More @ https://www.marketresearchfuture.com/reports/cardiovascular-application-market-5255

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Analysis and Regional Demand on Biomarker Technologies Market Forecast to 2023

According to Market Research Future (MRFR), the global biomarker technologies market share is expected to reach USD 78 billion, with a CAGR of 9% from 2017 to 2023 (forecast period).

The term biomarker is generally used to define a measurable indicator of a biological state or condition. The term also refers to a substance whose detection indicates the presence of a living organism. In medicine, a biomarker is referred to as a traceable material that is introduced into an organism to test the proper functioning of any organ. In cell biology, a biomarker is used as a medium for the detection of cellular defects, and for the isolation of a specific cell type (for example, Oct-4 protein is used as a biomarker for the identification of embryonic stem cells). In genetics, a biomarker or genetic marker is a stretch of the DNA sequence or oligonucleotide sequence that can be used to create genetic maps of any organism being studied. Biomarkers are used for diagnosis and clinical decision-making in cancer, diabetes, cardiovascular and neurological diseases.

Market Dynamics

The market for biomarker technologies is rising exponentially under the influence of increased incidences of cancer, diabetes, cardiovascular and neurological diseases. Moreover, developments in the field of medical technology, government initiatives to promote research in the field of biomarker technologies, and an increase in the use of biomarkers to improve the accuracy of disease diagnosis are expected to spur market growth.

Market Segmentation

The global biomarker technologies market is segmented based on product type, profiling technology, disease application, and research areas.

Based on product type, the global biomarker technologies market is divided into consumables, instruments, services, and software/informatics.

Based on profiling technology, the global biomarker technologies market is segmented into imaging technology, immunoassay, PCR, NGS, chromatography, cytogenetics, mass spectrometry, and other technologies. The immunoassay segment is further segmented into ELISA, western blot, and protein microarray.

Based on disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

Based on research areas, the global market for biomarker technologies is segmented into metabolomics genomics, Proteomics, and other research areas. The metabolomics segment is further segmented into lipidomic and others.

Regional Analysis

Regionally, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas are expected to account for the largest share of the market in biomarker technologies. The growing prevalence of cancer, cardiovascular disorders, neurological and autoimmune diseases and an increasing geriatric population are likely to propel the growth of the biomarker technologies market. For example, the National Cancer Institute (NCI) reported that there were 1,666,540 new cases of cancer in the United States in 2014. As a result, this increasing patient pool is expected to accelerate market growth during the forecast period. In addition, factors such as growing government initiatives and funding for research, the development of advanced medical treatment options, and the availability of favorable refund policies are likely to fuel the growth of the biomarker technology market in the American region. In addition, according to CMS (Centers for Medicare and Medicaid Services) U.S. health care spending risen by 4.3% to reach USD 3.3 trillion per person in 2016. As a result, rising personal per capita incomes and increasing health care spending, are likely to help boost America's market growth.

Europe is the second-largest market leader and holds a healthy share of the global market for biomarker technologies. The European market is expected to have a robust growth rate during the forecast period due to the availability of extensive treatment facilities and established healthcare infrastructure, along with a growing need for an effective and accurate diagnosis. According to Cancer Research UK, around 9,921 cases were diagnosed in 2015. These increasing incidences of cancer are expected to have a substantial impact on the market for biomarker technologies due to its widespread use in cancer. This impact would boost the biomarker technologies market in Europe.

The Asia Pacific is anticipated to be the fastest emerging market in the world. Factors such as the growing prevalence of chronic diseases are the key drivers of market development. For example, as per the International Diabetes Federation, almost 382 million people worldwide had diabetes in 2013. It is expected to reach around 500 million by the end of 2035. China and India are the first and second most affected diabetes nations. Increasing numbers of diabetic patients may lead to an increase in the number of patients with cardiovascular disease. As a result, these countries are anticipated to be the fastest-growing regions due to an increasing patient pool, health awareness, and the availability of new treatment methods. Moreover, increasing healthcare expenditure and growing living standards in the region are fueling the growth of the biomarker technologies market in the Asia Pacific region.

The Middle East and Africa are expected to report the least growth in the market due to some key factors such as lack of awareness and limited access and availability of treatment facilities. Throughout the Middle East, the United Arab Emirates is the largest market due to the growth of the healthcare sector and the growing availability of specialty care centers. With an increasing number of infectious diseases in the country, several key players are eager to set up their research and development centers to find a cure for these diseases. This will boost the use of biomarkers and, as a result, a steady growth rate could be seen during the forecast period.

Key Players

Some of the significant participants in the global biomarker technologies market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Roche, Waters Corporation, Danaher Corporation, Shimadzu Corporation, Danaher Corporation, Siemens Healthcare.

Read More @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comprehensive Analysis on Lab-on-a-Chip Device Market Size, Trends, Research Report and Forecast to 2023

Lab-on-a-Chip Device Market Information: Product (Instruments, Reagents & Consumables), Technology (Microarrays, Microfluidics), Application (Point of Care Diagnostics), and End-User (Biotechnology and Pharmaceutical Companies) – Global Forecast Till 2023

Market Highlights

The Lab-on-a-Chip Market trends is forecasted to exhibit robust growth registering a CAGR of 10% during the forecast period. The global Lab-on-a-Chip Market size is majorly driven by increasing application of lab on chip devices in the medical field in the diagnosis of various infectious diseases which eases sample handling and yields efficient results in a snap of time. Similarly, the use of lab-on-a-chip devices in research purposes is gaining traction due to easy portability, automated biochemical assays, and huge sample handling provision. Moreover, rising demand for miniature devices, advancing fabrication technology, research on biosensors and biomarkers, and economic feasibility of lab-on-a-chip devices are expected to spur the market growth. However, initial higher purchasing rate, as well as lack of awareness about the use of lab-on-a-chip devices in middle-income countries, are major restraints to the market growth.

Get Latest Sample Copy @ https://www.marketresearchfuture.com/sample_request/6215

Regional Analysis

Americas is the market leader and has an attractive market for lab on chip devices owing to increasing advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases. Additionally, factors such as increasing number of genomic and proteomics research labs government initiatives and funding for research, development of advanced medical treatment options, and rising demand for portable devices are likely to enhance the growth of Lab-on-a-Chip Market size in the American region. For instance, According to stats presented in the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years in the U.S. received an influenza vaccine. Due to the alarming rate of chronic as well as infectious diseases, use of lab-on-a-chip devices is accelerated due to its precision in diagnosis and multiple samples handling feature.

Europe is the second largest market and holds a healthy share in the global Lab-on-a-Chip Market size due to major driving factors such as the flourishing medical device market, favorable government initiatives to promote life-science and clinical research, rising average per capita income of individuals. For instance, the European Commission stated that the R&D spending by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D along with the ongoing legislative reforms is expected to have a positive impact on the Lab-on-a-Chip Market size.

The Asia-Pacific is expected to be the fastest growing market owing to the faster adaptation of healthcare technology, increasing patient pool of chronic and infectious diseases, government initiatives of healthcare reform, increasing number of CROs and research projects on environmental issues. Furthermore, key medical device players have set up their regional headquarters and manufacturing plants in Singapore, China, Japan, and Australia thus, boosting the growth of Lab-on-a-Chip Market size.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of the healthcare industry and sound economic status of inhabitants. However, this area has the possibility to grow during the forecast period as due to increasing outbreak of new opportunistic pathogen associated diseases like Ebola, Zika Virus, and Hepatitis B which has attracted key players to set up their R&D centers in this region.

Access Report @ https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

Industry Trends:

A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.

Segmentation:

The global LoC device market can be segmented by product, technology, application, and end-user.

Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses.

Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.

By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Trends on Body Contouring Devices and Procedures Market Size, share Growth and Demand

Market Highlights:

The Global Body Contouring Devices and Procedures Market. held a market value of USD 2,103 million in 2017 and is projected to grow at a CAGR of 6.6% over the forecast period.Body contouring is a altering the body part by improving the appearance. It involves the removal or transfer of fat to the body.

Get sample Copy @ https://www.marketresearchfuture.com/sample_request/6935

Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of urgery with advanced technologies may hamper the market growth during the assessment period.

Regional Analysis:

On regional basis, the Americas is anticipated to dominate the global body contouring devices and procedures market size owing to the growing R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region. Europe is expected to hold the second largest position in the global body contouring devices and procedures market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Asia Pacific has served an opportunity for developing body contouring market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like diabetes and obesity. The Middle East & Africa has the least share of the global body contouring devices and procedures market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Segmentation:

The global body contouring devices and procedures market has been segmented into type, procedure, and end user. By type, the market has been segmented into non-invasive & minimally invasive devices and invasive devices. The non-invasive & minimally invasive devices segment is estimated to hold major market share in the global body contouring devices and procedures market due to the huge investments by major market players for the development of advanced technologies and equipment.

Based on procedure, the market has been segmented into non-surgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others. The market, by end user, has been segmented into hospitals & clinics, research institutes & Organization, and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/body-contouring-devices-and-procedures-market-6935

Key Players:

Some of the prominent players in the global body contouring devices and procedures market are Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd, Bausch Health Companies, Inc, Lumenis, Merz Pharma GmbH & Co., Palomar Medical Technologies Inc., Sound Surgical Technologies LLC., Zeltiq Aesthetics, Chromogenex Technologies LTD, UltraShape Ltd, Fotona, Misonix Inc., Medicis Pharmaceutical Corporation, Sientra Inc., Invasix Ltd, Erchonia Inc, Lutronic.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Thursday 25 June 2020

Cruciate Ligament Repair Procedures Market Shares Analysis, Key Development Strategies and Forecasts Till 2023

Cruciate Ligament Diagnosis & treatment Market Research Report: Injury Type (Grade I, II, III), Product (Cement Implants, Cement-Less Implants), Indication (Osteoarthritis, RA), Treatment (Surgery), End-User (Hospitals, ASCs) – Global Forecast Till 2023

Market Highlights

The cruciate ligament treatment includes numerous surgical techniques that involve reconstruction and replacement of the knee and related ligaments. The upsurge in obese population is considered as a chief factor emphasizing the growth of this market. Obesity in the aging population has been reported to directly increase the risk of degenerative bone disorders, such as osteoporosis and osteoarthritis, additionally resulting in target injury and fracture owing to the extra pressure exerted on joints. Later, increasing number of people who have osteoporosis is expected to generate demand for the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6080

However, the lack of availability of skilled professionals and the high cost of treatment procedures may hinder the growth of the market during the forecast period.

Many prominent players in the market have incorporated into acquisitions, mergers, and continuous launches of quality systems to hold the market position. The firms are focusing on mergers and acquisitions to enhance their product portfolio. For instance, the acquisition of Cayenne Medical by Zimmer Biomet was involved in reconstruction solutions and advanced soft tissue repair for knee, shoulder, and extremities. Besides, companies are involving into geographic expansions to cater to the untargeted population for tissue repair and surgeries.

Regional Analysis

The global Cruciate Ligament Repair Procedures Market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa.

The American region holds the major share of the global cruciate ligament diagnosis and treatment market, owing to the existing well-established healthcare system, increasing prevalence of degenerative bone disorder cases, and technological advancements. Sports such as soccer, football, and skiing have been reported to be high-risk sports that can cause injury to the ACL when compared to other sports activities. For instance, due to increasing occurrences of ACL injuries, nearly 100,000 ACL reconstructions are performed each year as per a report published by PubMed.

Europe holds the second position in the global cruciate ligament diagnosis and treatment market. It is expected that the government support towards research and development expenditure and rising prevalence of chronic bone diseases are likely to drive the European cruciate ligament diagnosis and treatment market.

The Asia Pacific cruciate ligament diagnosis and treatment market consist of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for cruciate ligament diagnosis and treatment due to an increase in the prevalence of cancer and demand for cruciate ligament diagnosis and treatment techniques. In China, factors responsible for the market growth are rising geriatric population with osteoporosis diseases and availability of low-cost diagnostic and treatment options.

The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Access Report @ https://www.marketresearchfuture.com/reports/cruciate-ligament-diagnosis-treatment-6080

Segmentation

The global cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.

Based on type, the global cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).

The segments for injury type for the global cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.

On the basis of product, the global cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.

Based on indication, the global cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.

The diagnosis segment for the global cruciate ligament diagnosis and treatment market is classified as imaging and others. The imaging segment is further classified as abdominal x-ray, Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, angiography, and others.

Based on treatment, the global cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.

On the basis of end-user, the global cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Center (ASC), and others.

Global Cruciate Ligament Diagnosis & Treatment Key Players

Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), DeRoyal Industries, Inc. (U.S.), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others are some prominent players in this market.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Biomarker Technologies Market Industry Status, Key Regions, Application, Top Key Players, Future and Forecast Till 2025

Biomarker Technologies Market Information: By Product (Consumables, Instruments), by Profiling Technology (PCR, Imaging Technology, NGS), by Disease Application (Cancer, Infectious Disease), Research Area (Genomics, Proteomics) – Global Forecast Till 2023

Market Insights

Biomarkers have a broad spectrum of clinical uses and in medicine. It is critical in both diagnostics and ascertaining the best treatment route. Largely used for cancer, biomarkers and biomarker technology market is growing in use and is experiencing increasing demand. Market Research Future has performed a detailed study on the market and all its factors to ascertain that the market is likely to witness a CAGR of 99% during the forecast period of 2018 to 2023 and reach an estimated USD 78 bn by the end of the review period.

Biomarkers are effective for various medical applications besides diagnosis. They can be helpful in disease prevention, drug target identification, and several others. The growing global prevalence of chronic diseases, neurological disorders & diseases, and cardiovascular diseases; these are the result of growing urbanization, and changing global environment. The high demand for biomarker technologies is driven primarily by the advancement of medical technologies, and the growing investments in healthcare and medical sectors across the world. Moreover, governments and the associated government health, medicine, & drug bodies are highly supportive of biomarkers and biomarker technologies research and development. The increasing use of biomarkers in an effort to produce accurate diagnoses is additionally expected to support market growth over the assessment period.

The high capital investments required for the development of biomarkers and discovery of the same combined with the high cost of the use of biomarker technology is expected to restrain market growth. However, growing research and advancement in the field has brought biomarker technology a long way and is expected to contribute significantly to a wide scope for future growth.

Market Segmentation

MRfR's segmental assessment has been performed on the basis of product type, profiling technology, disease application, research areas, and region. By product type, the market is segmented into instruments, consumables, services, and software/informatics.

Based on profiling technology, the market is segmented into PCR, imaging technology, immunoassay, mass spectrometry, chromatography, NGS, cytogenetics, and other technologies. Further sub-segments are available for immunoassay in the report.

By disease application, the market is segmented into infection diseases, neurological, cardiovascular disorders, autoimmune diseases, cancer, and other disorders.

Based on research areas, the market is segmented into proteomics, metabolomics, genomics, and other research areas. Metabolomics is sub-segmented to include lipidomic and others.

Regional Analysis

The global biomarker technologies market is analyzed globally and divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Led by North America, the Americas account for the largest share of the global biomarker technologies market. There are a high prevalence of cancer, diabetes, cardiovascular, neurological, and autoimmune diseases which have led to a skyrocket in demand for effective diagnostic and treatment technologies. Moreover, the presence of steadily rising geriatric population , increased initiatives from the government, increasing funding for research and the growing availability of favorable reimbursement policies is expected to drive demand, and development of the technology. High growth is expected from the region in the coming years as health care spending has risen and the availability of ample opportunities for growth.

Meanwhile, the Asia-Pacific is projected to witness rapid growth at the highest CAGR, globally. The presence of a massive population pool, with growing incidences of chronic diseases, has proven to be a significant driver of growth. China and India are two of the most highly affected countries with a high diabetic population. These countries are fast emerging markets, due to the highly supportive government policies surrounding healthcare, increased funding for investment, and health care and the growing, rising disposable income which has led to increased healthcare spending by patients.

Key Players

MRFR's analysis of the competitive landscape of the market reveals several key players that are driving the market with their research & development, patent filing and use of other market driving strategies. Prominent market players include Waters Corporation, Danaher Corporation, Shimadzu Corporation, Seimens Healthcare, Bio-Rad Laboratories, and Abbott Laboratories among others.

Latest Industry News

Immunexpress has received a Notice of US Patent Allowance for its patent application for "validating biomarker measurement." This is part of its SeptiCyte technology and is expected to prove useful in the diagnosis of sepsis.

The European Medicines Agency (EMA), has provided a positive qualification opinion regarding the use of biomarkers as a vital tool to increase clinical trials on Parkinsons Disease. The biomarker tool in this purpose would assist trials by providing measurements which allow medical professionals to choose people most suitable for Parkinson's clinical trials.

QIAGEN N.V has partnered with multiple organizations to support the set up of a global genomics campus in Manchester U.K. to promote innovation and research of molecular diagnostics.

Read more @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Baby Monitors Market Forecast Covering Growth Inclinations & Development Strategies until 2025

Global Advanced Baby Monitors Market: Information by Product (Stationary and Wearable), by End User (Home Care and Day Care) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Global Advanced Baby Monitors Market Overview

Baby monitors are used to remotely monitor the movements of the baby, usually when the infant is far away or out of sight of the parent. Baby monitors simply the process of tracking the baby’s movement. With a rise in the shift towards the adoption of nuclear family system, this device comes in handy for single and working parents. This, in turn, is contributing to the ascension of the global advanced baby monitors market over the forecast period.

According to Market Research Future (MRFR) in their latest report, the global advanced baby monitors market is expected to upscale at a 9.2% CAGR through the forecast period of 2018-2025. Different factors contributing to this ascension include the introduction of advanced baby monitors, rapid urbanization, a mounting number of nuclear families, and elevating levels of disposable income. These advanced baby monitors now include video monitoring as well as the provision of healthcare-related support such as heartrate monitoring and body temperature monitoring. Because of these extensive features on advanced baby monitors, the market is witnessing fast-paced adoption of the product in urban areas. Furthermore, easier connectivity and portability of them are promoting higher usage and shift towards advanced baby monitors, driving the global market.

Detailed Regional Analysis

The global advanced baby monitors market is regionally segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas are expected to yield the highest percentage of total revenue in the global advanced baby monitors market over the forecast period. The region also dominated the market at the beginning of the forecast period, accounting for 48% of the total share. Also, the presence of various market giants in the region is likely to push exponential growth to the regional market, upscaling it at 9.42% CAGR by 2025.

Europe is expected to reach a market valuation of USD 603.38 million by the end of the review period, with a 9.31% CAGR through the forecast period. Fast-Paced growth in the e-commerce industry of the region is likely to drive the regional market for advanced baby monitors.

Asia Pacific is projected to showcase the most accelerated growth rate during the assessment period and is likely to exhibit a 9.54% CAGR by 2025. Attributable factors include the fast-paced economic growth in India and China and a rising disposable income, along with proliferated growth in the literacy rate.

Key Players

The global advanced baby monitors market is highly influenced by the strategies undertaken by various market vendors. These market vendors include Angelcare (Canada), The First Years, Inc. (U.S.), Mayborn Group (U.K.), Samsung Electronics Co. Ltd. (South Korea), Lorex Technology Inc. (Canada), Summer Infant, Inc. (U.S.), MonDevices (U.S.), Snuza International (South Africa), Owlet Baby Care (U.S.), MOTOROLA HOME (U.S.), Graco Children's Products, Inc. (U.S.), Safety 1st (U.S.), and Koninklijke Philips N.V. (Netherlands).

Industry Update

February 2019: BT recently announced the launch of Smart Baby Monitor, which is the UK’s first voice-controlled smart baby monitor, which can be controlled using Alexa and Google Assistant.

Market Segmentation

The global baby monitors market size is studied by Market Research Future (MRFR) for different types of products and the end-users of these advanced baby monitors. Different types of baby monitors included in the extensive study are stationary baby monitors and wearable baby monitors. At the beginning of the forecast period, the stationary baby monitors held 80% of the share in the global advanced baby monitors market. The demand and adoption of stationary baby monitors are anticipated to register a 9.09% CAGR and cross the revenue valuation of USD 1491.85 million by the end of 2025. On the other hand, the wearable baby monitors are also exhibiting a high level of demand, witnessing a 9.61% CAGR through the forecast period.

Advanced baby monitors are highly used for home care and daycare. In the base year, around 87% of total baby monitors were used for home care and are anticipated to scale valuation of USD 1660.94 million by the end of the assessment period. The adoption of baby monitors for home care is likely to upscale at 9.39% by 2025.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

News: AI in drug discovery Market Booming in Healthcare Industry

The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height.

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes.

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery.

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market.

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI applications in drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.

Read More @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Major Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others.

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics;

By Product Type : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology : Machine Learning, Deep Learning, and others.

By Indication : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions : Americas, Europe, Asia Pacific, and Rest-of-the-World.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com